Introducing SurfaceSeek™, SignalingSeek™, ImmuneSeek™, and ResistanceSeek™ – optimized for fresh & FFPE human tumors.
Sapient Launches Tumor Protein Mapping Platform to Characterize Functional Biology Across Critical Dimensions in Human Tumors
Introducing SurfaceSeek™, SignalingSeek™, ImmuneSeek™, and ResistanceSeek™ – optimized for fresh & FFPE human tumors.
Directly measure proteins that are truly accessible on the tumor cell surface, enabling confident target identification.
Directly measure phosphorylation-driven signaling activity in human tumors to characterize functional pathway activation.
Directly measure immune cell states & signaling pathways in human tumors to characterize immune activity & response.
Directly measure protein networks that drive therapeutic resistance in human tumors to characterize resistance mechanisms.
Why proteins & metabolites give a more complete picture of biology, and how AI is finally unlocking this needed data.
This paper details the use of Sapient’s discovery metabolomics method to uncover an early biomarker of HIE.
Measure proteins & PTMs directly, at scale – covering 5,400+ proteins in plasma and 12,000+ in tissue matrices.
Measure the proteins that matter most to your study – precisely, quantitatively, and at scale.
How our comprehensive library of 13,000+ reference standards enhances the speed, quality & extent of metabolite identification.